Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2023 06:30 ET | Source: Verve Therapeutics

Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results

U.S. Food and Drug Administration (FDA) Clears Investigational New Drug Application for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia (HeFH) Collaboration with Eli Lilly and...
October 31, 2023 06:01 ET | Source: Verve Therapeutics

Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3

BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene...
May 17, 2019 15:45 ET | Source: National Lipid Association

National Lipid Association Releases Official Scientific Statement Regarding Use of Lipoprotein(a) in Clinical Practice

JACKSONVILLE, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of an official scientific statement on Lipoprotein(a) [Lp(a)] clinical use at...
February 07, 2017 09:30 ET | Source: National Lipid Association

PCSK9 Barriers Survey Results Revealed at National Lipid Association Conference

PHOENIX, AZ--(Marketwired - February 07, 2017) - As part of its Spring Clinical Lipid Update (CLU) in Phoenix, the National Lipid Association (NLA) will reveal the results of its "Challenges in...